Aperture Bio

Micrographia Bio

This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.

ionSIGHT

This company develops an AI-driven mass spectrometry platform for drug developers to analyse protein structures and interactions for pharmaceutical discovery.

1Cell.Ai

The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.

Portal Biotech

The company develops nanopore-based instruments for single-molecule protein sequencing to serve researchers in drug discovery, diagnostics and biosecurity sectors.

One Biosciences

One Biosciences develops an AI-powered single-cell transcriptomic platform to provide functional tumour profiling for oncologists and pharmaceutical companies.

Lightcast Bio

This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.

Aperiam Bio

The company uses computer vision to design stable, high-performing proteins for customers in the cosmetics, therapeutics, and technical reagents sectors.

Constellate Proteomics

This company develops single-molecule protein analysis platforms for biopharmaceutical drug developers to monitor antibody quality and rank cell lines during production.